Greenoaks
Greenoaks is a San Francisco-based private venture capital and growth equity firm founded by Neil Mehta that invests globally from seed to growth stage, concentrating on AI (Anthropic, Sierra, Cyera), enterprise software, fintech, biotech, and emerging technology companies.
- Company typePrivate
- Founded2013
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Greenoaks does
Greenoaks is a privately held San Francisco-based investment firm (Greenoaks LLC) founded by Neil Mehta, operating as a global venture capital and growth equity investor in technology companies. The firm deploys capital across stages from seed through growth equity into a concentrated set of verticals — predominantly AI (Anthropic, Sierra, Cyera, WorkOS, Nava, Pax, Mind Robotics, Glow), enterprise software and fintech (Revolut, Brex), biotech and healthcare (NewLimit, Alan, Vetic), and emerging tech such as micromobility (ALSO, a Rivian spin-out) and industrial robotics (Mytra). Geographic footprint spans the United States, Canada, Europe (France, Belgium, Spain), the United Kingdom, Brazil, India, Singapore, and Israel, executed through a compact team of 11–50 employees led by Mehta, managing partner Benny Peretz, director of research Mac Steele, and principal Anlei Tang.
Greenoaks' business model is a standard venture capital structure: it raises capital from limited partners, invests into portfolio companies, and earns revenue through management fees on assets under management plus carried interest on profitable exits — neither figure is publicly disclosed. Pricing is therefore not applicable at the portfolio company level; rather, the firm writes checks ranging from sub-$50M seed rounds (Pax, Nava, Vetic) to multi-billion-dollar growth rounds (Anthropic $65B Series H, Revolut $75B secondary). The firm's go-to-market relies on founder relationships, institutional syndicate partnerships (Sequoia, Founders Fund, Altimeter, Dragoneer, Bessemer, Index, Tiger Global, GV, Coatue), and selective lead positions, with an unusually high frequency of co-lead or lead roles relative to its small headcount.
The firm has no proprietary technology products or disclosed AI/ML capabilities of its own; its platform is investment judgment, capital deployment capacity, and syndicate relationships. Notable infrastructure signals include a recent $10 million endowment gift from founder Neil Mehta to the Harker School for a student venture investment initiative, and reported fundraising activity for a separate $100M–$500M political endowment vehicle pitched to Silicon Valley billionaires, suggesting the firm is evolving beyond a pure fund-management model into adjacent influence and ecosystem-building activities.
Greenoaks firmographics
Firmographics- Name
- Greenoaks
- Legal name
- Greenoaks LLC
- Website
- https://greenoaks.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Greenoaks is a San Francisco-based private venture capital and growth equity firm founded by Neil Mehta that invests globally from seed to growth stage, concentrating on AI (Anthropic, Sierra, Cyera), enterprise software, fintech, biotech, and emerging technology companies.
- Ownership category
- akta.pro rank
Greenoaks industry classification
Industry- Product category
- Venture Capital and Growth Equity Investment
- NAICS
- All Other Financial Investment Activities (52399)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Technology & Software Growth Equity (FSANACAA)
- akta.pro secondary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
Keywords
Where Greenoaks is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Greenoaks business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Greenoaks product offering
Product offeringCore offering
Greenoaks is a private investment firm that deploys venture capital and growth equity into technology companies across multiple stages (seed through Series H) and sectors including AI, enterprise software, fintech, healthcare, biotech, cybersecurity, robotics, micromobility, and consumer technology. The firm invests as both lead and participating investor, deploying capital alongside institutional co-investors in major funding rounds globally.
Product overview
Greenoaks is a venture capital investment firm that provides growth capital and investment services to technology companies. As an investment firm, Greenoaks does not offer a traditional product portfolio but rather deploys capital into portfolio companies across various sectors including AI, healthcare, fintech, and consumer technology.
Differentiator
Problem solved
Functional benefit
Companies that use Greenoaks
Customer profileSegments1 record
Ideal customer profiles1 record
Greenoaks technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Greenoaks partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Harker SchoolminorGreenoaks founder Neil Mehta provided $10 million endowment gift to Harker School for Venture Investment Initiative enabling select seniors to make real investments in startups.
Scale indicators10 records
Recent moves6 records
Expansion highlights5 records
Greenoaks competitors and assessment
Company assessmentDirect peers
- Index Ventures: Global venture and growth firm with strong European and US presence. Co-invested with Greenoaks in Alan's €100M round and Glow; comparable in stage breadth and global tech mandate.
- Insight Partners: Software-focused growth equity and venture firm. Comparable in stage breadth, technology orientation, and ability to deploy multi-hundred-million-dollar checks into growth-stage companies.
- Founders Fund: Technology-focused venture firm investing from seed through growth. Co-led NewLimit's Series C with Greenoaks; directly comparable as a deep-tech oriented investor writing multi-stage checks.
- Andreessen Horowitz (a16z): Major venture and growth firm investing across AI, enterprise software, fintech, and bio. Comparable to Greenoaks in stage breadth, sector focus on technology, and ability to write large growth-stage checks.
- General Catalyst: Multi-stage venture and growth firm investing across technology, healthcare, and fintech. Comparable in sector breadth and stage range (seed through growth).
- Sequoia Capital: Premier venture and growth equity firm investing across technology stages globally. Greenoaks repeatedly co-invests with Sequoia (Anthropic, Sierra, Cyera, Eon, Glow), making it the closest direct comparable in mandate and check size.
- Coatue Management: Technology-focused investment firm deploying capital across public and private markets. Co-led Anthropic's Series G alongside Greenoaks participation; highly comparable in growth-stage tech focus and willingness to write mega-checks.
- Tiger Global Management: Growth-stage technology investor known for large, fast deployments. Co-led Sierra's Series E alongside Greenoaks participation; directly comparable in late-stage tech check writing.
- Altimeter Capital: Technology-focused investment firm with growth equity mandate. Co-led Anthropic's $65B Series H with Greenoaks; directly comparable in mega-check growth-stage tech investing.
- Dragoneer Investment Group: Growth-oriented technology investor frequently co-investing with Greenoaks (Anthropic Series H, Revolut secondary). Highly comparable in mandate and stage.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Greenoaks social profiles
Digital presenceGreenoaks financial estimates
Financial estimateRevenue estimate
Valuation estimate
Greenoaks leadership team
Management profileNumber of profiles
Profiles4 records
Greenoaks funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Greenoaks M&A and investment
M&A and investmentM&A
Investments201 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Greenoaks
What does Greenoaks do?
Greenoaks is a private investment firm that deploys venture capital and growth equity into technology companies across multiple stages (seed through Series H) and sectors including AI, enterprise software, fintech, healthcare, biotech, cybersecurity, robotics, micromobility, and consumer technology. The firm invests as both lead and participating investor, deploying capital alongside institutional co-investors in major funding rounds globally.
Is Greenoaks a public or private company?
Greenoaks is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Greenoaks founded?
Greenoaks was founded in 2013. It employs 11 to 50 people.
Where is Greenoaks based?
Greenoaks is headquartered in San Francisco, United States, in the North America region.
Who are Greenoaks's main competitors?
Direct peers on record are Index Ventures, Insight Partners, Founders Fund, Andreessen Horowitz (a16z), General Catalyst, Sequoia Capital, Coatue Management, Tiger Global Management, Altimeter Capital and Dragoneer Investment Group.
Does Greenoaks have an API?
No public API is recorded for Greenoaks.
What industry is Greenoaks in?
Greenoaks's product category is Venture Capital and Growth Equity Investment. Its primary akta.pro industry code is FSANACAA, Technology & Software Growth Equity, with a secondary code of FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 52399 and its SIC code is 6282.